Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of July 2019, with a specific reporting date of July 12, 2019. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) with the company.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively details specific share acquisition transactions.
| Transaction Type | Instrument | Price per Share | Total Volume | Date |
|---|---|---|---|---|
| Acquisition (Dividend Re-investment) | Ordinary Shares (25p each) | £16.5060 | 293 shares | July 11, 2019 |
Note: The total volume of 293 shares represents the aggregate of 10 individual transactions executed by various executives and their associates.
Material Changes
No material changes to the company's financial position, operations, or strategy are reported in this filing. The document solely records routine share acquisitions resulting from the re-investment of dividends paid on July 11, 2019, under the Company's Share Reward Plan.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a regulatory disclosure of specific equity transactions.
Investor Verification Checklist
- Verify that the share acquisitions were executed strictly through the Company's Share Reward Plan as a result of dividend re-investment.
- Confirm the transaction price of £16.5060 aligns with the market price on the London Stock Exchange (XLON) on July 11, 2019.
- Review the full list of PDMRs involved to ensure compliance with insider trading regulations (transactions involved the CEO, Presidents of Global Vaccines and Pharmaceuticals, and other senior officers).
- Note that this filing does not provide updated financial performance data; refer to the most recent Form 20-F or quarterly earnings release for financial metrics.